News > Roche’s Antibody Cocktail launched in India at Rs 59,750/dose; Cipla to market drug in country

Roche’s Antibody Cocktail launched in India at Rs 59,750/dose; Cipla to market drug in country

Drug majors Roche India and Cipla on Monday announced launch of Roche’s Antibody Cocktail in India priced at Rs 59,750 per dose for the treatment of mild to moderate COVID-19 in patients who are at high risk.

“The first batch of the Antibody Cocktail (Casirivimab and Imdevimab) is now available in India while a second batch will be made available by mid-June.” Cipla and Roche said in a joint statement.